| Financial Year |
March 31 2023 |
| Monetary Funds |
35,088,002.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,004,913.31 |
| Accounts Receivable |
923,749,141.69 |
| Advances to Suppliers |
21,564,843.60 |
| Other Receivables |
36,682,264.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,003,614.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,198,083.88 |
| Total Current Assets |
1,652,419,891.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,693,382.44 |
| Long-term Equity Investment |
56,523,541.68 |
| Investment Properties |
68,710,788.10 |
| Fixed Assetes |
43,237,519.46 |
| Under-construction Projects |
4,738,919.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,787,129.02 |
| R&D expenses |
-- |
| Goodwill |
50,758,751.17 |
| Long-Term Deferred and Prepaid Expenses |
1,193,822.90 |
| Deferred Income Tax Assets |
177,106,764.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
479,215,153.94 |
| Total Assets |
2,131,635,045.51 |
| Short-Term Loans |
142,512,051.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,573,915.50 |
| Accounts Payable |
807,640,246.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,834,815.89 |
| Taxes Payable |
14,792,746.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
266,883,474.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,570,968.28 |
| Other Current Liabilities |
117,208,855.67 |
| Sub-Total of Current Liabilities |
1,469,501,488.95 |
| Long-term Loans |
62,744,819.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,542,235.42 |
| Deferred Income Tax Liabilities |
638,252.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
107,363,773.68 |
| Total Liabilities |
1,576,865,262.63 |
| Paid-In Capital(Or Share Stock) |
135,312,808.00 |
| Capital Surplus |
448,494,386.62 |
| Surplus Reserve |
29,385,820.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-96,243,022.16 |
| Minority Stockholder's Interest |
27,805,434.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
526,964,347.97 |
| Owner's Equity（Stockholder's Equity） |
554,769,782.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,131,635,045.51 |
